<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Danaher | Press Releases</title>
<link>https://investors.danaher.com/</link>
<description></description>
<item>
<title>Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa</title>
<link>https://investors.danaher.com/2026-06-29-Danaher-Foundation-Commits-1-Million-to-Ebola-Outbreak-Relief-Efforts-in-Central-Africa</link>
<description>&lt;p&gt;The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the...&lt;/p&gt;</description>
<pubDate>Mon, 29 Jun 2026 08:30:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-06-29-Danaher-Foundation-Commits-1-Million-to-Ebola-Outbreak-Relief-Efforts-in-Central-Africa</guid>
</item>
<item>
<title>Danaher Schedules Second Quarter 2026 Earnings Conference Call</title>
<link>https://investors.danaher.com/2026-06-22-Danaher-Schedules-Second-Quarter-2026-Earnings-Conference-Call</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting...&lt;/p&gt;</description>
<pubDate>Mon, 22 Jun 2026 16:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-06-22-Danaher-Schedules-Second-Quarter-2026-Earnings-Conference-Call</guid>
</item>
<item>
<title>Danaher Completes Acquisition of Masimo Corporation</title>
<link>https://investors.danaher.com/2026-06-10-Danaher-Completes-Acquisition-of-Masimo-Corporation</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of...&lt;/p&gt;</description>
<pubDate>Wed, 10 Jun 2026 08:55:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-06-10-Danaher-Completes-Acquisition-of-Masimo-Corporation</guid>
</item>
<item>
<title>Danaher to Present at Bank of America Securities Healthcare Conference</title>
<link>https://investors.danaher.com/2026-05-06-Danaher-to-Present-at-Bank-of-America-Securities-Healthcare-Conference</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas,...&lt;/p&gt;</description>
<pubDate>Wed, 06 May 2026 16:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-05-06-Danaher-to-Present-at-Bank-of-America-Securities-Healthcare-Conference</guid>
</item>
<item>
<title>Danaher Announces Quarterly Dividend</title>
<link>https://investors.danaher.com/2026-05-05-Danaher-Announces-Quarterly-Dividend</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to...&lt;/p&gt;</description>
<pubDate>Tue, 05 May 2026 16:30:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-05-05-Danaher-Announces-Quarterly-Dividend</guid>
</item>
<item>
<title>Danaher Announces Pricing of Euro-Denominated Senior Notes Offering</title>
<link>https://investors.danaher.com/2026-04-22-Danaher-Announces-Pricing-of-Euro-Denominated-Senior-Notes-Offering</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of...&lt;/p&gt;</description>
<pubDate>Wed, 22 Apr 2026 19:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-04-22-Danaher-Announces-Pricing-of-Euro-Denominated-Senior-Notes-Offering</guid>
</item>
<item>
<title>Danaher Reports First Quarter 2026 Results</title>
<link>https://investors.danaher.com/2026-04-21-Danaher-Reports-First-Quarter-2026-Results</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are...&lt;/p&gt;</description>
<pubDate>Tue, 21 Apr 2026 06:00:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-04-21-Danaher-Reports-First-Quarter-2026-Results</guid>
</item>
<item>
<title>Danaher Schedules First Quarter 2026 Earnings Conference Call</title>
<link>https://investors.danaher.com/2026-03-20-Danaher-Schedules-First-Quarter-2026-Earnings-Conference-Call</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April 21, 2026 beginning at 8:00 a.m. ET and lasting...&lt;/p&gt;</description>
<pubDate>Fri, 20 Mar 2026 16:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2026-03-20-Danaher-Schedules-First-Quarter-2026-Earnings-Conference-Call</guid>
</item>
<item>
<title>Danaher Announces Quarterly Dividend</title>
<link>https://investors.danaher.com/2026-02-24-Danaher-Announces-Quarterly-Dividend</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to...&lt;/p&gt;</description>
<pubDate>Tue, 24 Feb 2026 16:30:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-02-24-Danaher-Announces-Quarterly-Dividend</guid>
</item>
<item>
<title>Danaher to Present at TD Cowen Health Care Conference</title>
<link>https://investors.danaher.com/2026-02-24-Danaher-to-Present-at-TD-Cowen-Health-Care-Conference</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday,...&lt;/p&gt;</description>
<pubDate>Tue, 24 Feb 2026 16:05:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-02-24-Danaher-to-Present-at-TD-Cowen-Health-Care-Conference</guid>
</item>
<item>
<title>Danaher To Acquire Masimo Corporation</title>
<link>https://investors.danaher.com/2026-02-17-Danaher-To-Acquire-Masimo-Corporation</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading...&lt;/p&gt;</description>
<pubDate>Tue, 17 Feb 2026 08:00:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-02-17-Danaher-To-Acquire-Masimo-Corporation</guid>
</item>
<item>
<title>Danaher Reports Fourth Quarter and Full Year 2025 Results</title>
<link>https://investors.danaher.com/2026-01-28-Danaher-Reports-Fourth-Quarter-and-Full-Year-2025-Results</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and...&lt;/p&gt;</description>
<pubDate>Wed, 28 Jan 2026 06:00:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-01-28-Danaher-Reports-Fourth-Quarter-and-Full-Year-2025-Results</guid>
</item>
<item>
<title>Danaher CEO to Comment on Financial Performance</title>
<link>https://investors.danaher.com/2026-01-12-Danaher-CEO-to-Comment-on-Financial-Performance</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in...&lt;/p&gt;</description>
<pubDate>Mon, 12 Jan 2026 09:00:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-01-12-Danaher-CEO-to-Comment-on-Financial-Performance</guid>
</item>
<item>
<title>Danaher to Present at J.P. Morgan Healthcare Conference</title>
<link>https://investors.danaher.com/2026-01-05-Danaher-to-Present-at-J-P-Morgan-Healthcare-Conference</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California...&lt;/p&gt;</description>
<pubDate>Mon, 05 Jan 2026 16:15:00 -0500</pubDate>
<guid>https://investors.danaher.com/2026-01-05-Danaher-to-Present-at-J-P-Morgan-Healthcare-Conference</guid>
</item>
<item>
<title>Danaher Schedules Fourth Quarter 2025 Earnings Conference Call</title>
<link>https://investors.danaher.com/2025-12-17-Danaher-Schedules-Fourth-Quarter-2025-Earnings-Conference-Call</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2026 beginning at 8:00 a.m. ET and...&lt;/p&gt;</description>
<pubDate>Wed, 17 Dec 2025 07:30:00 -0500</pubDate>
<guid>https://investors.danaher.com/2025-12-17-Danaher-Schedules-Fourth-Quarter-2025-Earnings-Conference-Call</guid>
</item>
<item>
<title>Danaher Announces Quarterly Dividend</title>
<link>https://investors.danaher.com/2025-12-09-Danaher-Announces-Quarterly-Dividend</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to...&lt;/p&gt;</description>
<pubDate>Tue, 09 Dec 2025 16:15:00 -0500</pubDate>
<guid>https://investors.danaher.com/2025-12-09-Danaher-Announces-Quarterly-Dividend</guid>
</item>
<item>
<title>Danaher to Present at Jefferies Global Healthcare Conference</title>
<link>https://investors.danaher.com/2025-11-11-Danaher-to-Present-at-Jefferies-Global-Healthcare-Conference</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global Healthcare Conference in London, UK on Tuesday,...&lt;/p&gt;</description>
<pubDate>Tue, 11 Nov 2025 16:15:00 -0500</pubDate>
<guid>https://investors.danaher.com/2025-11-11-Danaher-to-Present-at-Jefferies-Global-Healthcare-Conference</guid>
</item>
<item>
<title>Danaher Reports Third Quarter 2025 Results</title>
<link>https://investors.danaher.com/2025-10-21-Danaher-Reports-Third-Quarter-2025-Results</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 26, 2025. Key Third Quarter 2025 Results Net earnings were $908 million, or $1.27 per...&lt;/p&gt;</description>
<pubDate>Tue, 21 Oct 2025 06:00:00 -0400</pubDate>
<guid>https://investors.danaher.com/2025-10-21-Danaher-Reports-Third-Quarter-2025-Results</guid>
</item>
<item>
<title>Danaher Schedules Third Quarter 2025 Earnings Conference Call</title>
<link>https://investors.danaher.com/2025-09-23-Danaher-Schedules-Third-Quarter-2025-Earnings-Conference-Call</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October 21, 2025 beginning at 8:00 a.m. ET and lasting...&lt;/p&gt;</description>
<pubDate>Tue, 23 Sep 2025 16:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2025-09-23-Danaher-Schedules-Third-Quarter-2025-Earnings-Conference-Call</guid>
</item>
<item>
<title>Danaher Announces Quarterly Dividend</title>
<link>https://investors.danaher.com/2025-09-09-Danaher-Announces-Quarterly-Dividend</link>
<description>&lt;p&gt;Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to...&lt;/p&gt;</description>
<pubDate>Tue, 09 Sep 2025 16:15:00 -0400</pubDate>
<guid>https://investors.danaher.com/2025-09-09-Danaher-Announces-Quarterly-Dividend</guid>
</item>
</channel>
</rss>
